Cargando…
Emerging evidence on heterologous COVID-19 vaccine schedules—To mix or not to mix?
Autores principales: | Parker, Edward P K, Desai, Shalini, Marti, Melanie, O'Brien, Katherine L, Kaslow, David C, Kochhar, Sonali, Olayinka, Folake, Cravioto, Alejandro, Nohynek, Hanna, Hombach, Joachim, Wilder-Smith, Annelies |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906806/ https://www.ncbi.nlm.nih.gov/pubmed/35278358 http://dx.doi.org/10.1016/S1473-3099(22)00178-5 |
Ejemplares similares
-
Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
por: Parker, Edward P K, et al.
Publicado: (2022) -
Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023) -
Expecting the unexpected with COVID-19 vaccines
por: Bar-Zeev, Naor, et al.
Publicado: (2021) -
What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?
por: Wilder-Smith, Annelies
Publicado: (2022) -
COVID-19 vaccine strategies must focus on severe disease and global equity
por: McIntyre, Peter B, et al.
Publicado: (2022)